Gabriella Camboni

E-3810 Is a Potent Dual Inhibitor of VEGFR and FGFR that Exerts Antitumor Activity in Multiple Preclinical Models

Ezia Bello, Gennaro Colella, Valentina Scarlato et al. · Cancer Research · 2011 · 141 citations · Full text

Antitumor Activity, Family Members, Potent Dual Inhibitor +18

Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma

Duncan I. Jodrell, T.R. Jeffry Evans, William P. Steward et al. · European Journal of Cancer · 2004 · 129 citations

Esophageal Cancer, Gastrointestinal Oncology, Medicine +7

Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex

Cristiana Sessa, Giuseppe Capri, Luca Gianni et al. · Annals of Oncology · 2000 · 75 citations

Medicinal Chemistry, Bioorganic Chemistry, Daily Times Five +7

Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.

Guido Basilisco, A Bozzani, Gabriella Camboni et al. · Gut · 1985 · 56 citations · Full text

Medicine, Physiology, Mouth-to-caecum Transit Time +11

Oral naloxone antagonizes loperamide-induced delay of orocecal transit

Guido Basilisco, Gabriella Camboni, A Bozzani et al. · Digestive Diseases and Sciences · 1987 · 54 citations

Medicine, Neuropharmacology, Pharmacotherapy +4